Since lapatinib has limited cytocidal efficacy, and eEF-2 kinase may regulate the sensitivity of tumour cells, we investigated the effect of eEF-2 kinase inhibition on NPC sensitivity to lapatinib. Here, EEF2K is linked to neoplasm.